Equities

Penta Valent Tbk PT

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PEVE:JKT

Penta Valent Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)510.00
  • Today's Change-5.00 / -0.97%
  • Shares traded706.70k
  • 1 Year change+77.08%
  • Beta--
Data delayed at least 10 minutes, as of Mar 04 2026 08:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Penta Valent Tbk is engaged in the distribution of pharmaceutical products, medical equipment and consumer products. The pharmaceutical products or medicines and medical devices distributed by the Company are divided into several types, including ethical products, which are medicines sold in limited quantities and require a doctor’s prescription; Over The Counter products, which are medicines sold freely; Medical Devices, which are medical supporting devices such as blood pressure monitors, nebulizer, kateter, and others; Reagents, which are reaction materials such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, and others; as well as Food Supplements. Its distribution of consumer goods, which is divided into two types of products, namely Cosmetics: products for beauty and skin care, including makeup, perfume, skin nutrition, and others; and Toiletries: products for daily cleanliness and hygiene such as soap, shampoo, toothpaste, lotion, and other.

  • Revenue in IDR (TTM)3.41tn
  • Net income in IDR59.91bn
  • Incorporated2015
  • Employees1.48k
  • Location
    Penta Valent Tbk PTKedoya Utara Kebon JerukJI Kedoya raya no 33JAKARTA BARAT 11520IndonesiaIDN
  • Phone+62 215673891
  • Websitehttps://www.pentavalent.co.id/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.